Targeted Treatment for ADHD

From Treating the Illness to Treating the Individual

ADHD is a brain disorder characterized by an ongoing pattern of inattention and hyperactivity-impulsivity that interferes with everyday functioning.¹

There are a couple of key behaviors related to the disorder which manifest differently from person to person. Some people with ADHD have both inattention and hyperactivity-impulsivity behaviors, while others experience just one type of behavior. In the United States, approximately 5% of the population has ADHD.²

Making careless mistakes, being easily distracted, and not seeming to listen when spoken to are some symptoms of inattention. Hyperactivity-impulsivity symptoms can range from talking nonstop to being unable to sit still. Children often have a combination of the two behaviors of ADHD. Children with ADHD may receive a diagnosis during their elementary school years and symptoms can appear between the ages of 3 to 6.¹

Studies have shown that one of the causes of ADHD is genetics. In a 2017 study researchers funded by the National Institutes of Health released the results of the largest brain imaging study of those with ADHD ever conducted. It showed that people with ADHD have different brain structures. In the past, it was estimated that 50% of parents with a child with ADHD had the disorder too. Scientists now estimate that 75% of those with ADHD have genetic drivers.³

ADHD is a lifelong disorder. While there is no cure for ADHD, genetic testing may play a helpful role in determining a treatment plan to help manage symptoms.

Find the Right ADHD Treatment

Genetic testing can provide a personalized approach for clinicians to treat patients’ ADHD. It can help them prescribe an even more individualized treatment plan, taking into account a patient’s own genetic makeup, in addition to the medical history and environmental and lifestyle factors that clinicians already consider when treating patients.

Since every patient is unique, personalized medicine, including genetics, can help provide a treatment plan for ADHD that is a better match.

Genomind® Professional PGxTM

Genomind Professional PGx is a genetic cheek swab test that looks at key genes in your DNA that can affect how you may respond to medication for depression. It identifies patient-specific genetic markers that can indicate for your clinician which treatments are likely to work as intended, have no effect, or cause adverse effects.

Watch a short overview

More on ADHD

} ); } ( jQuery ) );